William Quinn Biography and Net Worth

Willie Quinn, Chief Financial Officer, joined Bolt Biotherapeutics in 2020. Prior to joining Bolt, Willie served as the chief financial officer and senior vice president corporate development of Sunesis Pharmaceuticals (SNSS). He led Sunesis’ fundraising and partnering efforts, raising over $60 million in public funding and signing multiple deals with industry partners. Prior to Sunesis he led Bullet Biotechnology, a company that he co-founded to develop cancer immunotherapies based on technology from Stanford University, as chief executive officer. Willie was instrumental in establishing the infrastructure at Jazz Pharmaceuticals (JAZZ), where he was one of the first employees and worked for more than eight years. He rose to head of corporate development, also overseeing strategy and investor relations, helping Jazz transform from a private startup to a public, profitable specialty pharmaceutical company. Before Jazz, Willie was the chief financial officer and chief operating officer of Novation Biosciences, a biotechnology software company that was acquired by Agilent Technologies. He currently serves on the board of A Foundation Building Strength, a nonprofit with a mission to find treatments for Nemaline Myopathy. Willie earned an M.A. and B.A. from Stanford University and an M.B.A. from the Stanford Graduate School of Business.